WHO initiative to combat medicines-related corruption
Anti-corruption specialists are to join experts in medicines in a new
initiative launched by the World Health
Organization.
The WHO is establishing an expert group drawn from international institutions
to combat corruption in medicines regulation and procurement.
According to the WHO, corrupt practices allow the entry of counterfeit
and substandard products into the medicines supply chain as well as resulting
in a loss of resources and posing a danger to patients’ lives.
The WHO plans to strengthen regulatory authorities and procurement practices
by stimulating legislative reform, promoting standardised systems for
the selection of regulatory and procurement staff and medical products,
and encouraging ethical practices through behaviour change and staff
training.
The WHO also plans to compile a database of best practices to promote
good governance in the public pharmaceutical sector.
|
The
Pharmaceutical Journal
Acrobat
Reader